Evolution in Oncology - Caris Life Sciences and ConcertAI скачать в хорошем качестве

Evolution in Oncology - Caris Life Sciences and ConcertAI

Caris Life Sciences Executive Vice President, Chief Medical Officer George Sledge, and ConcertAI CEO discuss how high-depth and population-scale clinico-genomic datasets will impact translational sciences, early-phase clinical trials, and clinical lifecycle management. Learn more: https://www.carislifesciences.com/pro... 0:00 - Intro 1:16 - More data is better 4:21 - Whole exome sequencing in large patient populations 6:02 - Analyzing the complexity of tumor biology 7:37 - Precision oncology approach 10:26 - Understanding the dynamic evolution of cancer 13:29 - The molecular revolution has begun 15:21 - Molecular signatures 18:53 - AI signatures: prediction of brain metastasis 22:14 - New drug indications and life cycle planning 25:59 - Caris Assure: blood-based profiling 30:02 - New opportunities for cancer prevention and precision medicine 33:13 - Caris and ConcertAI working together 34:03 - Question 1: Advice for assessing resistance mechanisms? 36:43 - Question 2: How long is a tumor’s molecular data relevant (tumor evolution)? 39:05 - Closing comments